Latest Biotechnology, Pharmaceutical and Healthcare News

14:35 EDT 1st September 2014 | BioPortfolio

Showing News Articles 1–25 of 640,000+

Monday 1st September 2014

Global Liver Diseases and Therapies Market- The Key Basics by Transparency Market Research

Transparency Market Research published a new report "Liver Diseases Therapeutics Market: Global Industry Analysis, Size, Share, Trends and Forecast 2012 - 2018" to its report store. Albany, New York (PRWEB) September 01, 2014 Liver is the largest organ inside the human body. Liver is the one vital organ that helps the body in barring itself from poisons, helps in digestion of food and a...

Sanofi-Aktie: Société Générale erhöht Kursziel nach klinischen Studiendaten zu "Alirocumab", kaufen! Aktienanalyse

Paris - Sanofi-Aktienanalyse von Analyst Stephen McGarry von der Société Générale: Stephen McGarry, Aktienanalyst der Société Générale, erhöht in einer aktuellen Aktienanalyse das Kursziel für die ...

Novartis's paradigm-shifting, blockbusting heart failure drug trounces enalapril

With the question of its efficacy and safety profile seeming in little doubt, speculation is now turning is how the drug will fare in the market against much cheaper generics products. As analysts at BioMedTracker noted, "The European discussant at t...

INTERVIEW: 23andMe uses people power to push personalized medicine into new fields

So far, the personalized approach has mainly been used in cancer to identify patients with certain genetic mutations who are more or less likely to respond to particular drugs. But 23andMe believes there is untapped potential in other diseases.

UCB's Vimpat scores US monotherapy approval, Europe to follow?

The FDA has also granted the use of new single loading dose administration option for all formulations of Vimpat in the US.

WHO calls for stronger action to reduce health risks from climate change

The World Health Organization has called for more concerted action worldwide to reduce the health risks associated with climate change. Backed by scientific experts at its first conference on health...

Cancer Drugs Fund receives boost but will no longer fund "overpriced" drugs

The Cancer Drugs Fund has been given a 40% increase in funding and has agreed to remove from its list any drugs that are overpriced or produce little clinical benefit. The fund’s chairman also...

B-cell Non-Hodgkin Lymphoma Treatment Market Value worth $5.4 Billion by 2018 Says a New Report Available at MarketOptimizer.org

MarketOptimizer.org adds “OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018” to its store. Overview of B-cell NHL, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines for DLBCL, FL, MZL and MCL. Dallas, Texas (PRWEB) September 01, 2014 The B-cell non-Hodgkin’s Lymphoma (NHL) treatment market value will expe...

Pricing is key for new heart drugs challenging cheap generics

BARCELONA (Reuters) - Doctors looking at highly encouraging clinical trial results for new heart drugs at the world's largest cardiology meeting this week are missing one piece of data that will be critical to their success - the price.

Ablynx signs RA deal with China's Eddingpharm

Ablynx signs RA deal with China's Eddingpharm

Poor response to Ebola causing needless deaths: World Bank head

DAKAR/LAGOS (Reuters) - The world's "disastrously inadequate response" to West Africa's Ebola outbreak means many people are dying who could easily be saved, the head of the World Bank said on Monday, as Nigeria confirmed another case of the highly c...

Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today

Women's hormonal imbalances cause unexpected weight gain. This mysterious onset of weight is no longer a mystery in the medical fields of Aging, Female Health and Weight Management as is discussed in detail during this hour interview with medical expert Dr. Maiysha Clairborne on Dr. Carol Francis Talk Radio Show today - Can’t Seem to Shed those Extra Pounds? With Dr. Clairborne Los Angeles (...

Poor response to Ebola causing needless deaths - World Bank head

* W.Bank chief says Ebola response "disastrously inadequate"

New Vaccine Unexpectedly Suppresses HIV infection Monkeys

A new vaccine has been found to stop rhesus macaque moneys from infection with SIV, the monkey form of the HIV virus An international research team, with scientists based in Paris-Descartes University in France, as well as the University of Chinese Medicine in Guangzhou, China, has developed a new orally administered vaccine that was found […]

Gilead Sciences-Aktie: schwächere Sovaldi-Verschreibungen erwartet! - Aktienanalyse

Toronto - Gilead Sciences-Aktienanalyse von Analyst Michael J. Yee von RBC Capital Markets: Michael J. Yee, Aktienanalyst von RBC Capital Markets, erwartet bei den Aktien des US-Biotechkonzerns Gil...

Europe: heart disease, stroke declining, but more people in hospital

Europe: heart disease, stroke declining, but more people in hospital

CH-Schluss: SMI nimmt dank Novartis Jahreshoch ins Visier

Zürich - Der Schweizer Aktienmarkt ist sämtlichen politischen Ereignissen zum Trotz dank Novartis sehr stark in die neue Woche gestartet. Der Swiss Market Index (SMI) hat am Berichtstag sein bishe...

Aktien Zürich verzeichnen mit Novartis-Plus deutlichen Aufschlag

Angetrieben von der Novartis-Aktie hat die Börse in Zürich am Montag mit einem deutlichen Plus die Sitzung geschlossen. Ein neues Medikament gegen Herzinsuffizienz stützte die Novartis-Titel. Der ...

Aktien Schweiz Schluss: SMI nimmt dank Novartis Jahreshoch ins Visier

Zürich (awp) - Der Schweizer Aktienmarkt ist sämtlichen politischen Ereignissen zum Trotz dank Novartis sehr stark in die neue Woche gestartet. Der Swiss Market Index (SMI) hat am Berichtstag sein ...

Human medicines European public assessment report (EPAR): Reasanz, serelaxin, Revision: 0, Refused

Ipsen receives priority review for sNDA for Somatuline

French drugmaker Ipsen has received priority review for its supplemental New Drug Application from the US Food and Drug Administration for Somatuline Depot injection.

Cipla's generic of GSK's Advair for asthma marks expansion into Europe

Indian generic drugmaker Cipla has entered the respiratory market in Germany and Sweden with its Serroflo (salmeterol/fluticasone MDI).

New EMA guidance on EU periodic-safety-update-report single assessment for nationally authorized medicines

The European Medicines Agency has updated its procedural guidance to ensure that marketing-authorization holders are prepared for the submission of periodic safety update reports (PSURs) for nationally authorized medicines subject to European Union s...

Boehringer plans new real-world data on Pradaxa

Five years on from the first breakthrough presentation of the pivotal RE-LY clinical trial of Pradaxa (dabigatran etexilate) for the prevention of stroke in non-valvular atrial fibrillation (NVAF), extensive clinical trial and real-world data support...

Novartis Leads Swiss Stocks Higher

BRUSSELS (dpa-AFX) - Swiss stocks rallied on Monday, led by Novartis after the drug maker presented findings on a potential breakthrough heart drug.The Swiss Market Index rose 1.05 percent to 8,74...


Search BioPortfolio:
Advertisement
Advertisement

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.